#psychotherapy

kennychaffin@diasp.org

All approaches also consider the relationship between the therapist and the person receiving therapy (the therapeutic relationship) to be an important factor – another part of the ‘what’ of therapy – that drives changes. Better outcomes are associated with: a strong bond; having a shared understanding of the problem; and working on a clear goal. Within therapy, one person experiences care and empathy from another. The person receiving therapy comes with positive expectations (or such expectations are shaped in therapy), so that during the therapy they become hopeful. Although what a person may ‘do’ in a session may vary, the activity of therapy provides them with the means with which to cope with their distress.

Most therapeutic approaches also aim to find ways to encourage people to face the internal experiences or situations that they have been avoiding because they find them uncomfortable or upsetting. This may occur at each point of a person’s engagement with therapy, including: at the point of making the appointment; when sitting with the therapist; talking to them about feelings; exploring the past and/or current difficulties in detail; and in making changes in day-to-day life. Through this process, the person is assisted and encouraged to learn to tolerate discomfort (or it may reduce over time), and the individual comes to think about their experiences differently. The individual learns something new, adapts their responses, implements changes, re-evaluates and so on… Reducing avoidance brings about change.

https://psyche.co/ideas/psychotherapy-under-the-microscope-how-exactly-does-it-work

#psychology #psychotherapy

garryknight@diasp.org

I’ve been meeting with the same group of men for 36 years – here’s what they’ve taught me | Men | The Guardian

When I saw a flyer for a ‘men’s group’ in a shop window, I was a young, buttoned-up and newly single father. More than three decades on, the conversations are still changing my life

An interesting and perhaps uplifting about the benefits of one particular mens' group. Many of the comments are interesting, too.

#health #MentalHealth #psychology #psychotherapy #counselling #MensGroups #men #interesting

https://www.theguardian.com/lifeandstyle/2022/jul/23/meeting-same-group-men-years-david-spiegelhalter

garryknight@diasp.org

MDMA trials under review in Canada over alleged abuse of study participants | Canada | The Guardian

All clinical trials into the psychoactive drug MDMA are being reviewed by Canadian regulators after complaints about abuse of study participants by a trailblazing American psychedelic research organization.
The California-based Multidisciplinary Association for Psychedelic Studies (Maps) has led the way in conducting trials into the medicinal qualities of the drug. In May 2021, it released results from a phase-three trial in the journal Nature on the benefits of the drug – commonly sold illegally as a powder or within ecstasy tablets – as a breakthrough treatment for PTSD, for which there is currently no effective pharmaceutical treatment.
But the government regulator Health Canada confirmed it had announced a review into the MDMA clinical trials sponsored by Maps that have in part been conducted in Canada, following a complaint that detailed “alleged investigator misconduct”.

#psychiatry #psychotherapy #DrugTreatment #MDMA #PTSD #trauma

https://www.theguardian.com/world/2022/jun/20/mdma-trials-canada-review-alleged-abuse

garryknight@diasp.org

Promising early results from largest-ever trial testing LSD for anxiety | New Atlas

Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can generate rapid and sustained reductions to anxiety, however, significantly larger trials will be needed to validate these findings.

#science #medicine #health #research #psychiatry #psychotherapy #drugs #LSD #anxiety

https://newatlas.com/science/lsd-for-anxiety-phase2-trial-mindmed-early-results/

garryknight@diasp.org

Europe’s first psychedelic drug trial firm to open in London | Drugs | The Guardian

Europe’s first commercial facility for psychedelic drug trials is to open in London, with the goal of making the UK a global leader in psychedelics research and innovation.
The British startup Clerkenwell Health aims to begin trials in its central London facility in August, initially focusing on the use of psilocybin to help people deal with the anxiety associated with a diagnosis of terminal illness, and to support them through their end-of-life care.

#science #medicine #health #MentalHealth #psychiatry #psychotherapy #TerminalIllness #PalliativeCare #drugs #psychedelics #psilocybin

https://www.theguardian.com/science/2022/may/09/europes-first-psychedelic-drug-trial-firm-to-open-in-london

garryknight@diasp.org

'I felt more joy than I thought possible' | BBC News

"I had the full-blown mystical revelatory experience - the big psychedelic multi-coloured light and sound show."
This is how Steve recalls his first dose of a hallucinogenic drug, psilocybin, the psychedelic compound found in magic mushrooms.

#science #medicine #health #psychiatry #psychotherapy #drugs #psilocybin

https://www.bbc.co.uk/news/science-environment-61106081

garryknight@diasp.org

‘Clients say it feels like we’ve always known each other’: the mental health experts who believe their autism has turbocharged their work | Mental health | The Guardian

Therapists, psychologists and nurses who are autistic say it has made them better at their jobs, but that misconceptions about the condition are forcing them to keep their diagnosis a secret

#science #medicine #health #autism #Aspergers #psychotherapy #psychology

https://www.theguardian.com/society/2022/feb/03/clients-say-it-feels-like-weve-always-known-each-other-the-mental-health-experts-who-believe-their-autism-has-turbocharged-their-work

garryknight@diasp.org

Blue Monday: Why it's a 'load of rubbish' | BBC News

Christmas is over, it's cold and dark outside and we're still in the middle of a global pandemic.
Blue Monday - also known as the most depressing day of the year - has been trending on Twitter since the weekend.
You might think it's relatable after the past year, but unsurprisingly, there's nothing scientific about it.

#psychology #psychiatry #psychotherapy #interesting

https://www.bbc.co.uk/news/newsbeat-51173730

garryknight@diasp.org

Psilocybin, in 10mg or 25mg doses, has no short- or long-term detrimental effects in healthy people | King's College

New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King’s College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously.

The research, published in The Journal of Psychopharmacology, is an essential first step in demonstrating the safety and feasibility of psilocybin – a psychedelic drug isolated from the Psilocybe mushroom – for use within controlled settings alongside talking therapy as a potential treatment for a range of mental health conditions, including treatment-resistant depression (TRD) and PTSD.

#science #medicine #health #psychiatry #psychotherapy

https://www.kcl.ac.uk/news/psilocybin-in-10mg-or-25mg-doses-has-no-short-or-long-term-detrimental-effects-in-healthy-people

garryknight@diasp.org

NHS to give therapy for depression before medication under new guidelines | Depression | The Guardian

Millions of people with mild depression in England should be offered therapy, exercise, mindfulness or meditation before antidepressants, according to the first new NHS guidelines in more than a decade.
Under draft guidance, the National Institute for Health and Care Excellence (Nice) recommends the “menu of treatment options” be offered to patients by health professionals before medication is considered.

#science #medicine #health #depression #psychotherapy #CBT

https://www.theguardian.com/society/2021/nov/23/nhs-to-give-therapy-for-depression-before-medication-under-new-guidelines

garryknight@diasp.org

Hacking enlightenment: can ultrasound help you transcend reality? - video | Life and style | The Guardian

Can technology improve the way we meditate? At the University of Arizona, Dr Jay Sanguinetti and master meditator Shinzen Young are using ultrasound to improve our ability to achieve mindfulness – as well as enhance our cognition and wellbeing. They believe it could revolutionise the way we treat those with depression and trauma. But as investors from Silicon Valley become interested in the technology, the pair are fighting to make sure the device is used in the right way and for the right reasons. [9'05" video]

Which is the better treatment for depression and trauma: medication or meditation?

#health #MentalHealth #psychology #psychotherapy #depression #trauma #meditation #technology #tech #ultrasound

https://www.theguardian.com/lifeandstyle/video/2021/jun/29/hacking-enlightenment-can-ultrasound-help-you-transcend-reality